About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3624036
Allelic
Composition
Tg(Ins1-Cat,Tyr)25Pne/0
Genetic
Background
NOD.FVB-Tg(Ins1-Cat,Tyr)25Pne
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Ins1-Cat,Tyr)25Pne mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• treatment of transgenic NOD mice with cyclophosphamide (CYP) accelerated NOD diabetes; 20 days after injection of CYP 63% of transgenic mice are diabetic compared with 7% of treated controls

immune system
• transgenic NOD male mice display a significant acceleration of the onset of spontaneous diabetes (over 85% at 200 days of age) compared to NOD controls (30-40% of male NOD mice)

endocrine/exocrine glands
• cultured islets of transgenic NOD mice are more sensitive to a mix of cytokines (Il-beta, Tnfa and Ifng) than NOD control islets as revealed by Caspase-3 activity
• beta cell damage is significantly increased in transgenic mice after CYP injection compared to controls; pancreatic insulin content is only 22% of original level after 8 days compared to 76% in control NOD mice

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
type 1 diabetes mellitus DOID:9744 OMIM:222100
J:108415


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/19/2024
MGI 6.23
The Jackson Laboratory